How Intestinal phosphate absorption pathways could pave the way for novel therapies of phosphate control?
Why is it hard for most patients to achieve target phosphate levels?
Summarize the pros and cons of common phosphate binders overtime.
Elevated phosphorus levels are associated with CV adverse events. What are the possible mechanisms? Why is there a lack in RCTs evaluating solid end-point outcomes?
Do you think the prevalence of CV disease and mortality in CKD decreased in recent years? Explain the possible causes.
